IN2012DN00711A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00711A
IN2012DN00711A IN711DEN2012A IN2012DN00711A IN 2012DN00711 A IN2012DN00711 A IN 2012DN00711A IN 711DEN2012 A IN711DEN2012 A IN 711DEN2012A IN 2012DN00711 A IN2012DN00711 A IN 2012DN00711A
Authority
IN
India
Prior art keywords
pharmaceutically active
layers
disclosed
active ingredient
layer
Prior art date
Application number
Other languages
English (en)
Inventor
Bruce Variano
Jeffrey Speck
Maria Teresa Sallent
Simone Evans
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of IN2012DN00711A publication Critical patent/IN2012DN00711A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
IN711DEN2012 2009-07-21 2010-04-07 IN2012DN00711A (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27139109P 2009-07-21 2009-07-21
PCT/US2010/030183 WO2011011099A1 (en) 2009-07-21 2010-04-07 Multi-layered gradient vaginal ring

Publications (1)

Publication Number Publication Date
IN2012DN00711A true IN2012DN00711A (OSRAM) 2015-06-19

Family

ID=42236498

Family Applications (1)

Application Number Title Priority Date Filing Date
IN711DEN2012 IN2012DN00711A (OSRAM) 2009-07-21 2010-04-07

Country Status (14)

Country Link
US (1) US8753667B2 (OSRAM)
EP (1) EP2456421B1 (OSRAM)
JP (1) JP5690826B2 (OSRAM)
CN (1) CN102497855B (OSRAM)
AU (1) AU2010274946B2 (OSRAM)
BR (1) BR112012001353B8 (OSRAM)
CA (1) CA2767967C (OSRAM)
CO (1) CO6491080A2 (OSRAM)
DK (1) DK2456421T3 (OSRAM)
ES (1) ES2626156T3 (OSRAM)
IN (1) IN2012DN00711A (OSRAM)
MX (1) MX2012000948A (OSRAM)
WO (1) WO2011011099A1 (OSRAM)
ZA (1) ZA201200809B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE202011110355U1 (de) * 2011-03-09 2014-01-15 Arstat, Inc. Behandlung von Uterusmyomen durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes
FR3005417B1 (fr) * 2013-05-10 2015-05-22 Blaise Francois Figuereo Anneau vaginal tri-reservoir, a retro-largage compatible avec les caracteristiques des molecules actives qu'il contient
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
DK2982352T3 (en) 2014-06-28 2018-11-26 Laboratorios Andromaco S A CERVICALLY PESSAR CONTAINING PROGESTERON FOR EXTENDED, LONG AND CONTINUOUS RELEASE USED TO PREVENT EARLY BIRTHS
US9943146B2 (en) 2015-05-27 2018-04-17 Qalo Llc Compression molded silicone ring
WO2017011571A1 (en) * 2015-07-14 2017-01-19 Qalo Llc Compression molded silicone ring
WO2017108676A1 (en) * 2015-12-21 2017-06-29 Bayer Oy Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
CN106913412B (zh) * 2017-03-01 2023-09-22 上海市嘉定区妇幼保健院 易放易取式子宫托
MX2020012458A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
CA3087410A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
EP4057994A4 (en) * 2019-11-12 2023-12-06 Poly-Med Inc. Contraceptive medical devices
DE102021100916A1 (de) 2021-01-18 2022-07-21 Carl Freudenberg Kg Verfahren zur Herstellung eines Bauteils, Werkzeug zur Durchführung des Verfahrens und Bauteil, das durch das Verfahren hergestellt ist
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL152819B (nl) 1949-04-07 Swift & Co Werkwijze voor het continu bereiden van mono-ammoniumdiwaterstoffosfaatdeeltjes en zo verkregen deeltjes.
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (OSRAM) 1953-11-19
GB804199A (en) 1955-12-22 1958-11-12 Midland Silicones Ltd Organosiloxane compositions
GB798669A (en) 1956-12-12 1958-07-23 Midland Silicones Ltd Improvements in or relating to organosiloxane elastomer foams
US2927907A (en) 1957-01-07 1960-03-08 Dow Corning Siloxane elastomers
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3035016A (en) 1959-03-16 1962-05-15 Dow Corning Acyloxy siloxanes and a method of using the
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4155991A (en) 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4596576A (en) 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
FR2598652B1 (fr) 1986-05-16 1988-08-05 Figuereo Blaise Machine d'extrusion simultanee de plusieurs matieres
US4922928A (en) 1988-08-17 1990-05-08 Michael Burnhill Vaginal device
ATE207736T1 (de) 1995-07-04 2001-11-15 Akzo Nobel Nv Ringförmige vorrichtung
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
WO2002076426A2 (en) 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
US7824383B2 (en) 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method

Also Published As

Publication number Publication date
CN102497855A (zh) 2012-06-13
ZA201200809B (en) 2012-10-31
CO6491080A2 (es) 2012-07-31
BR112012001353B1 (pt) 2020-04-14
MX2012000948A (es) 2012-02-28
US8753667B2 (en) 2014-06-17
CA2767967C (en) 2014-10-21
EP2456421A1 (en) 2012-05-30
JP2012533401A (ja) 2012-12-27
AU2010274946B2 (en) 2013-09-12
US20120148655A1 (en) 2012-06-14
BR112012001353B8 (pt) 2021-05-25
BR112012001353A2 (pt) 2016-04-05
CA2767967A1 (en) 2011-01-27
CN102497855B (zh) 2013-12-25
JP5690826B2 (ja) 2015-03-25
WO2011011099A1 (en) 2011-01-27
ES2626156T3 (es) 2017-07-24
AU2010274946A1 (en) 2012-03-01
EP2456421B1 (en) 2017-04-05
HK1169614A1 (en) 2013-02-01
DK2456421T3 (en) 2017-06-06

Similar Documents

Publication Publication Date Title
IN2012DN00711A (OSRAM)
AU2018256579A1 (en) Methods for preparing a skin graft
WO2008105715A3 (en) Use of lactobacillus plantarum for increasing bacterial diversity
MX337634B (es) Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos.
MX2009000379A (es) Preparacion farmaceutica para la administracion oral con liberacion controlada del ingrediente activo en el intestino delgado y metodo para su fabricacion.
EP4538227A3 (en) Sodium thiosulfate-containing pharmaceutical compositions
EP4509093A3 (en) Inflatable prostheses and methods of making same
DE602005002745D1 (de) Medizinische vorrichtungen und verfahren zu ihrer herstellung
AU2003285923A1 (en) Braided stent and method for its manufacture
MX354144B (es) Metodo, fabricacion y uso de productos medicos que liberan sustancia activa para mantener vasos sanguineos abiertos.
IL201479A (en) Use of tapentadol for the preparation of pain medication
WO2008076706A3 (en) Implantable medical device with pharmocologically active ingredient
ATE498027T1 (de) Wirkstoffabgebende verbundkörper
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
WO2007146935A3 (en) Purchase option-based emergency supplies provisioning method
NZ610179A (en) Medical headgear
WO2010107570A3 (en) Self-locating and multiple application medical patch systems
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
WO2008016677A3 (en) Preparation and utility of deuterated amphetamines
ATE538819T1 (de) Medizinische vorrichtungen und verfahren zu ihrer herstellung
MX341727B (es) Sosten de tejido de punto sin costuras tubular y metodo de fabricacion del mismo.
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2012002773A3 (en) Phenylcarbamate compound and muscle relaxant containing the same
WO2015136377A3 (en) Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms